Antioxidant treatment in peripheral artery disease: the rationale is there, but what about clinical results?

Giannopoulos, Georgios; Angelidis, Christos; Vogiatzi, Georgia; Cleman, Michael W; Deftereos, Spyridon

Giannopoulos, Georgios; Angelidis, Christos; Vogiatzi, Georgia; Cleman, Michael W; Deftereos, Spyridon.

Afiliação

Giannopoulos G; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA. Electronic address: georgios.giannopolous@yale.edu.
Angelidis C; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
Vogiatzi G; 1st Department of Cardiology, University of Athens Medical School, Hippokration Hospital, Athens, Greece.
Cleman MW; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
Deftereos S; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA; 1st Department of Cardiology, University of Athens Medical School, Hippokration Hospital, Athens, Greece.

Curr Opin Pharmacol ; 39: 53-59, 2018 04.

Article em En | MEDLINE | ID: mdl-29486422

Assuntos

Antioxidantes/uso terapêutico; Doença Arterial Periférica/tratamento farmacológico; Humanos; Estresse Oxidativo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Arterial Periférica / Antioxidantes Limite: Humans Idioma: En Revista: Curr Opin Pharmacol Assunto da revista: FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google